Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 940313

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery


Čačev, Tamara; Zapletal, Emilija; Musani, Vesna; Rako, Ivana; Lončar, Božo; Aralica, Gorana; Kapitanović, Sanja
Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery // Anticancer research, 38 (2018), 5; 2841-2848 doi:10.21873/anticanres.12529 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 940313 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery
(Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer)

Autori
Čačev, Tamara ; Zapletal, Emilija ; Musani, Vesna ; Rako, Ivana ; Lončar, Božo ; Aralica, Gorana ; Kapitanović, Sanja

Izvornik
Anticancer research (0250-7005) 38 (2018), 5; 2841-2848

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
MSH2 gene ; LOH ; mRNA expression ; immuno histochemistry ; IVS10+12G>A ; sporadic colon cancer
(MSH2 gene ; LOH ; mRNA expression ; immunohistochemistry ; IVS10+12G>A ; sporadic colon cancer)

Sažetak
Background: mutS homolog 2 (MSH2) deficiency may be involved in the development of microsatellite instability found in certain sporadic colorectal tumors. In addition to mutations or loss of heterozygosity resulting in complete loss of MSH2 function, polymorphisms affecting MSH2 expression have been also identified. Therefore, the aim of this study was to examine MSH2 status in sporadic colon cancer. Materials and Methods: MSH2 status was examined at the DNA, RNA and protein levels through loss of heterozygosity (LOH) analysis, quantitative real-time PCR and immunohistochemistry. MSH2 IVS10+12A>G polymorphism was examined by real-time single nucleotide polymorphism genotyping. Results: MSH2 LOH was more frequent in tumors larger than 5 cm (p=0.032), mRNA expression was also significantly lower and the same expression pattern was present in the corresponding normal mucosa of the same patient (p=0.013 and p=0.008, respectively). No association was found between IVS10+12A>G polymorphism and susceptibility to sporadic colon cancer. Conclusion: Altered MSH2 expression detected in sporadic colon tumors pointing to its role in colorectal tumorigenesis without a hereditary component.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
098-0982464-2508 - Molekularna genetika i farmakogenetika gastrointestinalnih tumora (Kapitanović, Sanja, MZOS ) ( CroRIS)
HRZZ-IP-2016-06-1430 - Mikrosatelitna nestabilnost (MSI i EMAST) u molekularnom profiliranju sporadičnih karcinoma debelog crijeva (MSIandEMASTinCRC) (Kapitanović, Sanja, HRZZ - 2016-06) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"

Poveznice na cjeloviti tekst rada:

doi ar.iiarjournals.org

Citiraj ovu publikaciju:

Čačev, Tamara; Zapletal, Emilija; Musani, Vesna; Rako, Ivana; Lončar, Božo; Aralica, Gorana; Kapitanović, Sanja
Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery // Anticancer research, 38 (2018), 5; 2841-2848 doi:10.21873/anticanres.12529 (međunarodna recenzija, članak, znanstveni)
Čačev, T., Zapletal, E., Musani, V., Rako, I., Lončar, B., Aralica, G. & Kapitanović, S. (2018) Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery. Anticancer research, 38 (5), 2841-2848 doi:10.21873/anticanres.12529.
@article{article, author = {\v{C}a\v{c}ev, Tamara and Zapletal, Emilija and Musani, Vesna and Rako, Ivana and Lon\v{c}ar, Bo\v{z}o and Aralica, Gorana and Kapitanovi\'{c}, Sanja}, year = {2018}, pages = {2841-2848}, DOI = {10.21873/anticanres.12529}, keywords = {MSH2 gene, LOH, mRNA expression, immuno histochemistry, IVS10+12G>A, sporadic colon cancer}, journal = {Anticancer research}, doi = {10.21873/anticanres.12529}, volume = {38}, number = {5}, issn = {0250-7005}, title = {Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancery}, keyword = {MSH2 gene, LOH, mRNA expression, immuno histochemistry, IVS10+12G>A, sporadic colon cancer} }
@article{article, author = {\v{C}a\v{c}ev, Tamara and Zapletal, Emilija and Musani, Vesna and Rako, Ivana and Lon\v{c}ar, Bo\v{z}o and Aralica, Gorana and Kapitanovi\'{c}, Sanja}, year = {2018}, pages = {2841-2848}, DOI = {10.21873/anticanres.12529}, keywords = {MSH2 gene, LOH, mRNA expression, immunohistochemistry, IVS10+12G>A, sporadic colon cancer}, journal = {Anticancer research}, doi = {10.21873/anticanres.12529}, volume = {38}, number = {5}, issn = {0250-7005}, title = {Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer}, keyword = {MSH2 gene, LOH, mRNA expression, immunohistochemistry, IVS10+12G>A, sporadic colon cancer} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font